Cipla company profile

CIPLA · NSE · INR

Compare Cipla
₹1,415.00Change from previous close: −0.25%Absolute change: −₹3.50

Close · November 20, 2026

Company profile

Cipla has 31,369 employees and is headquartered in Mumbai, India.

Customers in India, the United States and South Africa, along with buyers in other countries, are the markets this Mumbai-based drugmaker serves. Its products include off-patent medicines sold as generics and under its own brand names, alongside vaccines and the active ingredients used to make finished drugs. The range covers treatments for respiratory conditions, HIV/AIDS, heart and kidney disease, diabetes, oncology, child health and critical care, and the company also runs consumer healthcare, biosimilars and specialty businesses.

In the fiscal year ended March 2026, revenue reached INR 278.3 billion, up 2.1% from the previous year, and net profit was INR 38.8 billion. The company has 31,369 employees. It was incorporated in 1935 and is headquartered in Mumbai, India.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Country
India
Headquarters
Cipla House, 400013, Mumbai
Employees
31,369
Chief executive
Achin Gupta
Founded
1935
Fiscal year
April - March
Listing
CIPLA · NSE
Currency
INR
ISIN
INE059A01026
Website
cipla.com

Cipla and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
CiplaCIPLAIndia$12.34B31,36913.0%39.5
Zhejiang NHU002001China$11.61B11,50833.8%10.6
Zydus LifesciencesZYDUSLIFEIndia$12.92B29,98017.2%28.7
Laurus LabsLAURUSLABSIndia$14.13B7,05924.1%97.8
Yunnan Baiyao Group000538China$15.07B9,28611.2%19.4
PharmaEssentia6446Taiwan$15.94B13138.4%74.1

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Cipla with its competitors